SlideShare a Scribd company logo
The life science business of Merck KGaA,
Darmstadt, Germany operates as
MilliporeSigma in the U.S. and Canada.
Emprove® Virtual
User Group
Meeting
Torsten Schadendorf
June 1st 2021
The life science business
of Merck KGaA, Darmstadt,
Germany operates as
MilliporeSigma in the U.S.
and Canada
Agenda
1
2
3
The Emprove® Program - an Overview
Emprove® CCM
Emprove® API Information Package
4 Technically Unavoidable Particle
Profiles (TUPPs) - An Update
The Emprove® Program –
an Overview
... Convenient
Access ...
... for a Broad
Portfolio.
... to reliable
information ...
The Emprove® Program
at a glance…
Emprove® Virtual User Group Meeting | June 1st 2021
5
Chemicals Expanding content
PharmaGradeTM Integration in progress
Filters & Single use Constant portfolio expansion, supporting launches
Chromatography Launched Q2/2020
Cell Culture Media Launched Q4/2020
Emprove® Material Qualification Dossier
Emprove® Quality Management Dossier
Emprove® Operational Excellence Dossier
Portfolio, Dossiers, Suite
Emprove® Program
Emprove® Suite
Emprove® Virtual User Group Meeting | June 1st 2021
6
POLL QUESTION 1
Title of Presentation | DD.MM.YYYY
7
Do the information in the Emprove® Dossiers and/or the Emprove® Suite
help you to assess the risk associated with (please check all that apply)?
o Raw Material Sourcing
o Raw Material Qualification
o Raw Material Performance
o All of the Above
Emprove® CCM
Product Scope
Emprove® CCM
In scope
 Chemically-defined media
 Selected media for Gene Editing
and Novel Modalities
 Custom Media
Product Family
Cellvento® media (wave 1)
EX-CELL® Advanced Media (wave 2)
EX-CELL® Insect Media (wave 2)
EX-CELL® Lenti Media (wave 2)
Custom Media (wave 3)
Emprove® Virtual User Group Meeting | June 1st 2021
9
Out of scope
Standard / classical media (eg. DMEM, GMEM)
Dossier Structure
Emprove® CCM
Emprove® Virtual User Group Meeting | June 1st 2021
10
Operational Excellence Dossier
 Trace Element Information
 Origin of Raw Materials
 Analytical procedures
Supports process optimization
Material Qualification Dossier
 General information
 Specification
 Manufacture
 Address, Manufacturing Flowchart,
ISO Cert, GMP Statement
 Homogeneity Statement
 Characterization Statements
 TSE/BSE, Virus Safety, GMO,
Components of Interest
 Control of CCM
 CoAs, Label, Batch Numbering
 Container closure system
 Stability
Information to start a material
qualification
Quality Management Dossier
 Supply Chain Information
 Product Quality Self Assessment
 Site Quality Self Assessment
 Supplier Management
 Stability data
Answers questions during risk
assessment
Dossier Structure
Emprove® CCM
Emprove® Virtual User Group Meeting | June 1st 2021
11
Operational Excellence Dossier
 Trace Element Information
 Origin of Raw Materials
 Analytical procedures
Supports process optimization
Material Qualification Dossier
 General information
 Specification
 Manufacture
 Address, Manufacturing Flowchart,
ISO Cert, GMP Statement
 Homogeneity Statement
 Characterization Statements
 TSE/BSE, Virus Safety, GMO,
Components of Interest
 Control of CCM
 CoAs, Label, Batch Numbering
 Container closure system
 Stability
Information to start a material
qualification
Quality Management Dossier
 Supply Chain Information
 Product Quality Self Assessment
 Site Quality Self Assessment
 Supplier Management
 Stability data
Answers questions during risk
assessment
Material Qualification Dossier
Emprove® CCM
Emprove® Virtual User Group Meeting | June 1st 2021
12
 Specification
 Originial Manufacturer
 ISO 9001 Certificate
Material Qualification Dossier
Emprove® CCM
Emprove® Virtual User Group Meeting | June 1st 2021
13
 Specification
 Originial Manufacturer
 ISO 9001 Certificate
 Manufacturing Process
 Validation Report - Open Part
 Packaging Material
 CoA (examples)
 Product label / batch
numbering system (example)
Material Qualification Dossier
Emprove® CCM
Emprove® Virtual User Group Meeting | June 1st 2021
14
 Specification
 Originial Manufacturer
 ISO 9001 Certificate
 Manufacturing Process
 Validation Report - Open Part
 Packaging Material
 CoA (examples)
 Product label / batch numbering
system (example)
 Certificates
 TSE/BSE
 Viral Safety
 GMO
 Homogeneity
 Components of Interest
Emprove® CCM
Material Qualification Dossier
Emprove® Virtual User Group Meeting | June 1st 2021
15
Quality Management
Emprove® CCM
Emprove® Virtual User Group Meeting | June 1st 2021
16
 IPEC-PQG GMP Guide applied to Cellvento®
media platform with scope of Emprove® Program
Dossier Structure
Emprove® CCM
Emprove® Virtual User Group Meeting | June 1st 2021
17
Operational Excellence Dossier
 Trace Element Information
 Origin of Raw Materials
 Analytical procedures
Supports process optimization
Material Qualification Dossier
 General information
 Specification
 Manufacture
 Address, Manufacturing Flowchart,
ISO Cert, GMP Statement
 Homogeneity Statement
 Characterization Statements
 TSE/BSE, Virus Safety, GMO,
Components of Interest
 Control of CCM
 CoAs, Label, Batch Numbering
 Container closure system
 Stability
Information to start a material
qualification
Quality Management Dossier
 Supply Chain Information
 Product Quality Self Assessment
 Site Quality Self Assessment
 Supplier Management
 Stability data
Answers questions during risk
assessment
Quality Management Dossier
Emprove® CCM
Emprove® Virtual User Group Meeting | June 1st 2021
18
Dossier Structure
Emprove® CCM
Emprove® Virtual User Group Meeting | June 1st 2021
19
Operational Excellence Dossier
 Trace Element Information
 Origin of Raw Materials
 Analytical procedures
Supports process optimization
Material Qualification Dossier
 General information
 Specification
 Manufacture
 Address, Manufacturing Flowchart,
ISO Cert, GMP Statement
 Homogeneity Statement
 Characterization Statements
 TSE/BSE, Virus Safety, GMO,
Components of Interest
 Control of CCM
 CoAs, Label, Batch Numbering
 Container closure system
 Stability
Information to start a material
qualification
Quality Management Dossier
 Supply Chain Information
 Product Quality Self Assessment
 Site Quality Self Assessment
 Supplier Management
 Stability data
Answers questions during risk
assessment
Operational Excellence Dossier
Emprove® CCM
Emprove® Virtual User Group Meeting | June 1st 2021
20
POLL QUESTION 2
Title of Presentation | DD.MM.YYYY
21
Please rank the following cell culture media information given in the
Emprove® dossiers regarding the value for you (1 = highest value)
o CCM stability data
o Levels of trace elements
o Origin of media components/ingredients
Is ranking within poll questions possible? If not, please use this question: “Which
of the following information shown before are of most value to you?”
Emprove® CCM
Dossier Availability (wave 1: Cellvento® media platform)
Emprove® Virtual User Group Meeting | June 1st 2021
22
Article Code Product
Emprove® Material
Qualification Dossier
Emprove® Quality
Management Dossier
Emprove® Operational
Excellence Dossier
103840 Cellvento® 4CHO-X COMP Expansion √ √ √
103796 Cellvento® 4Feed COMP New New New
103795 Cellvento® 4CHO New New New
101885 Cellvento® CHO-200 New New New
101883 Cellvento® Feed-200 New New New
102577 Cellvento® CHO-220 New New New
102578 Cellvento® Feed-220 New New New
102485 Cellvento® CHO-210 New New New
102488 Cellvento® Feed-210 New New New
Versioning
Emprove® CCM
Emprove® Virtual User Group Meeting | June 1st 2021
23
Emprove® API Information
Package
Emprove® Virtual User Group Meeting | June 1st 2021
25
Emprove® Essential
 GMP (IPEC)
 Moderate risk applications
Emprove® Expert
 GMP (IPEC)
 Higher risk applications
Emprove® API
 GMP (ICH Q7)
Chemicals Categories
Emprove® Evolve
 Non-GMP, manufactured utilizing
GMP concepts and elements
 Evolving regulatory needs
Emprove® Program for Chemicals
Content
Emprove® API Information Package
Emprove® Virtual User Group Meeting | June 1st 2021
26
 General Information
 Manufacture
 Manufacturer
 Certificate of GMP Compliance
 Description of Manufacturing Process
 Specification
 Other relevant product certificates
 Product Quality Self Assessment
 Packaging Information
 Stability Summary and Conclusion
Purpose: Supporting material qualification, not for registration purposes
Certificate of GMP Compliance (latest version available on EudraGMDP webpage*)
Emprove® API Information Package
Emprove® Virtual User Group Meeting | June 1st 2021
27
* http://eudragmdp.ema.europa.eu/inspections/gmpc/searchGMPCompliance.do;jsessionid=FdxKinNcvHto_mTjMJAtz3O1xm1iK0yrk07LmD-rcl4bCSJrozh6!814916889
Other relevant product certificates Package
Emprove® API Information Package
Emprove® Virtual User Group Meeting | June 1st 2021
28
 TSE/BSE
 Allergen
 Mycotoxin/Aflatoxin
 GMO
 Nitrosamine
 Melamine
 Kosher
 Halal
Stability Summary and Conclusion
Emprove® API Information Package
Emprove® Virtual User Group Meeting | June 1st 2021
29
POLL QUESTION 3
Title of Presentation | DD.MM.YYYY
30
Do you use APIs only for the intended use as API or (potentially) also in
other / adjacent applications (e.g. as excipients in critical formulations)?
o Only as API
o APIs and further/other applications
Versioning
Emprove® API Information Package
Emprove® Virtual User Group Meeting | June 1st 2021
31
Article Product Name Dossier Availability
108432 Urea cryst. EMPROVE®
API Ph Eur, BP, USP √
100164 Boric acid cryst., EMPROVE®
API Ph Eur, BP, NF √
105040 Potassium iodide EMPROVE®
API Ph Eur, BP, JP, USP √
109828 di-Potassium hydrogen phosphate anhydrous, low in sodium EMPROVE®
API Ph Eur, BP, USP √
106235 Sodium acetate trihydrate EMPROVE®
API Ph Eur, BP, JP, USP, FCC, E262 New
106666 tri-Sodium citrate dihydrate low in endotoxins, EMPROVE®
API Ph Eur, BP, JP, USP New
102465 Calcium chloride dihydrate EMPROVE®
API Ph Eur, BP, JP, USP New
102367 Magnesium chloride hexahydrate cryst. EMPROVE®
API Ph Eur, BP, JPC, USP New
500111 Cocarboxylase tetrahydrate EMPROVE®
API HY2 / 2021
500112 Cocarboxylase chloride thiamine diphosphoric acid ester chloride EMPROVE®
API HY2 / 2021
500667 Thiamine phosphoric acid ester chloride dihydrate EMPROVE®
API HY2 / 2021
106441 Sodium fluoride EMPROVE®
API Ph Eur, BP, USP HY2 / 2021
106444 Sodium chloride EMPROVE®
API Ph Eur, BP, JP, USP HY2 / 2021
108815 Zinc chloride EMPROVE®
API Ph Eur, BP, USP HY2 / 2021
106143 Meglumine low in endotoxins EMPROVE®
API Ph Eur, ChP, JP, USP HY2 / 2021
128204 Sodium acetate trihydrate EMPROVE®
API Ph Eur, BP, JP, USP, FCC, E262 HY2 / 2021
Expected Availability
Emprove® API Information Packages
32 Emprove® Virtual User Group Meeting | June 1st 2021
Technically Unavoidable
Particle Profiles (TUPPs) -
An Update
Detailed information for each type of TUP
From Reactive to Proactive
Emprove® Virtual User Group Meeting | June 1st 2021
34
 Intention, quality policy towards foreign particles
 Flow chart of manufacturing process (reference to MQD)
 TUP information
 Particle picture
 Identity and composition
 Mass balance
 Root cause
 Assessment of additional microbial and BSE risks
Detailed information for each type of TUP
Picture and Identity
35 Emprove® Virtual User Group Meeting | June 1st 2021
Detailed information for each type of TUP
Picture and Identity
Emprove® Virtual User Group Meeting | June 1st 2021
36
Availability
Technically Unavoidable Particle Profile (TUPP)
Emprove® Virtual User Group Meeting | June 1st 2021
37
Article Product
100419 Parteck®
M 200 (Mannitol) EMPROVE®
ESSENTIAL Ph Eur,BP,JP,USP,E 421
100494 Parteck® M 100 (Mannitol) EMPROVE® ESSENTIAL Ph Eur,BP,JP,USP,E 421
100892 Sucrose low in endotoxins suitable for use as excipient EMPROVE®
exp Ph Eur,BP,JP,NF
107653 Sucrose EMPROVE®
ESSENTIAL Ph Eur,BP,JP,NF
101816 Ammonium sulfate EMPROVE®
EXPERT ACS,NF
112120 Calcium carbonate precipitated (<= 0.0001% Al) EMPROVE®
ESSENTIAL Ph Eur,BP,USP,JP,FCC,E 170
102064 Calcium carbonate precipitated (<= 0.002% Fe) EMPROVE® ESSENTIAL Ph Eur,BP,USP,JP,FCC
106400 Sodium chloride EMPROVE® ESSENTIAL Ph Eur,BP,USP
116224 Sodium chloride low in endotoxins suitable for use as excipient EMPROVE® exp Ph Eur,BP,JP,USP
137017 Sodium chloride EMPROVE® EXPERT Ph Eur,BP,ChP,JP,USP
106482 Sodium hydroxide pellets EMPROVE® ESSENTIAL Ph Eur,BP,FCC,JP,NF,E 524
137020 Sodium hydroxide pellets suitable for the biopharmaceutical production EMPROVE® bio Ph Eur,BP,JP,NF
108346 D(+)-Glucose monohydrate EMPROVE® EXPERT Ph Eur,BP,USP
141350 Polyvinyl alcohol 4-88 EMPROVE® ESSENTIAL Ph Eur,USP,JPE
141351 Polyvinyl alcohol 8-88 EMPROVE® ESSENTIAL Ph Eur,USP,JPE
141352 Polyvinyl alcohol 26-88 EMPROVE® ESSENTIAL Ph Eur,USP,JPE
141353 Polyvinyl alcohol 40-88 EMPROVE® ESSENTIAL Ph Eur,ChP,USP,JPE
141354 Polyvinyl alcohol 5-88 EMPROVE® ESSENTIAL Ph Eur,USP,JPE
141355 Polyvinyl alcohol 18-88 EMPROVE® ESSENTIAL Ph Eur,ChP,USP,JPE
103583 Parteck® SI 150 (Sorbitol) EMPROVE® ESSENTIAL Ph Eur,BP,JP,NF,JSFA,E 420
115079 Parteck® SI 200 (Sorbitol) EMPROVE® ESSENTIAL Ph Eur,BP,JP,NF,E 420
112635 Parteck® Delta M (Mannitol) EMPROVE® ESSENTIAL Ph Eur,BP,USP,JP,E 421
100493 Parteck® M 300 (Mannitol) EMPROVE® ESSENTIAL Ph Eur,BP,JP,USP,E 421
137112 Poloxamer 188 EMPROVE® EXPERT
New
Technically Unavoidable Particle Profiles (TUPPs)
Emprove® Virtual User Group Meeting | June 1st 2021
38
Article Product TUPP part of Emprove® OED
105911 Maltose monohydrate EMPROVE® ESSENTIAL Mar 2021
104871 Potassium dihydrogen phosphate cryst., EMPROVE®
ESSENTIAL Ph Eur,BP,JPC,NF,E 340 May 2021
137039 Potassium dihydrogen phosphate cryst. EMPROVE®
EXPERT Ph Eur,BP,JPC,NF May 2021
105101 di-Potassium hydrogen phosphate anhydrous, EMPROVE®
ESSENTIAL Ph Eur,BP,E 340 May 2021
137010 di-Potassium hydrogen phosphate anhydrous EMPROVE®
EXPERT Ph Eur,BP,USP May 2021
106349 Sodium dihydrogen phosphate monohydrate EMPROVE®
ESSENTIAL BP,USP May 2021
137093 Sodium dihydrogen phosphate monohydrate EMPROVE®
EXPERT BP,USP May 2021
106574 di-Sodium hydrogen phosphate heptahydrate EMPROVE®
ESSENTIAL DAC,USP May 2021
137092 di-Sodium hydrogen phosphate heptahydrate EMPROVE®
EXPERT DAC,USP May 2021
106398 Sodium carbonate anhydrous EMPROVE® ESSENTIAL Ph Eur,BP,JP,NF June / July
137012 Sodium acetate trihydrate EMPROVE®
EXPERT Ph Eur,BP,JP,USP June / July
105032 Potassium hydroxide pellets EMPROVE®
ESSENTIAL Ph Eur,BP,JP,NF,FCC,E 525 TUPP to be created
Emprove® Suite Notification System
Last but not least
Receive a monthly digest of the updates that were
made in the previous month to:
 Emprove® Operational Excellence Dossiers
 Emprove® Quality Management Dossiers
1 Click on “Be notified of changes to
subscription documents”
2 Submit your name and confirm the notification
3
The vibrant M, SAFC, Millipore, Cellvento, and Emprove are trademarks of Merck KGaA, Darmstadt, Germany or its affiliates. All other trademarks are the
property of their respective owners. Detailed information on trademarks is available via publicly accessible resources.
© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

More Related Content

PDF
Project Management In Pharmaceutical Industry
PDF
Technology transfer 14 p5 millili
PDF
Viral safety of biologics: What's changing with the ICH Q5A revision?
PPTX
Quality Control for Medical Device Software - It Arena Lviv Presentation
PDF
Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...
PDF
Production and purification of Viral vectors for gene and cell therapy appli...
PPTX
Quality risk managment basic facilitation methods
PDF
Design Controls: Building Objective Evidence and Process Architecture to Mee...
Project Management In Pharmaceutical Industry
Technology transfer 14 p5 millili
Viral safety of biologics: What's changing with the ICH Q5A revision?
Quality Control for Medical Device Software - It Arena Lviv Presentation
Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...
Production and purification of Viral vectors for gene and cell therapy appli...
Quality risk managment basic facilitation methods
Design Controls: Building Objective Evidence and Process Architecture to Mee...

What's hot (20)

PPTX
Medical Devices Regulation (MDR) 2017/745 - Identification, traceability
PDF
Clinical Trials Strategy: The Clinical Development Plan
PDF
Usp biotherapeutics - biological medicines
PDF
Developing a Scalable Upstream Bioreactor Process for Lentiviral Vector Produ...
PPTX
Safety Data Exchange Agreements (Brief)
PDF
Virus Safety in Vaccine Production
PPTX
ISO 10993-5 Biological Evaluation of Medical Devices - Tests for In Vitro Cyt...
PDF
Clinical Evaluation in the EU for Medical Devices: Understanding the Changes ...
PPTX
EU Medical Device Regulatory Framework_Dec, 2022
PPTX
Computerized System Validation : Understanding basics
PDF
Good Laboratory Practices by Dr. A. Amsavel
PPTX
Agile in Medical Software Development
PPTX
Biosimilars and Development
PPTX
21 CFR Part 11 checklist software.pptx
PPTX
Ppt on glp by deepak kumar
PPTX
2. Ppt on GLP
PPTX
Process development
PPTX
Novartis industrial training overview
PPTX
ANDA Stability Requirements
PPTX
GOOD LABORATORY PRACTICES
Medical Devices Regulation (MDR) 2017/745 - Identification, traceability
Clinical Trials Strategy: The Clinical Development Plan
Usp biotherapeutics - biological medicines
Developing a Scalable Upstream Bioreactor Process for Lentiviral Vector Produ...
Safety Data Exchange Agreements (Brief)
Virus Safety in Vaccine Production
ISO 10993-5 Biological Evaluation of Medical Devices - Tests for In Vitro Cyt...
Clinical Evaluation in the EU for Medical Devices: Understanding the Changes ...
EU Medical Device Regulatory Framework_Dec, 2022
Computerized System Validation : Understanding basics
Good Laboratory Practices by Dr. A. Amsavel
Agile in Medical Software Development
Biosimilars and Development
21 CFR Part 11 checklist software.pptx
Ppt on glp by deepak kumar
2. Ppt on GLP
Process development
Novartis industrial training overview
ANDA Stability Requirements
GOOD LABORATORY PRACTICES
Ad

Similar to The Emprove® Program: Introduction of New Portfolio Additions (20)

PDF
The Emprove® Program: an introduction focussing on the Emprove® Suite and Emp...
PDF
Program - 5th Annual Biomanufacturing Summit 2013, San Diego
PDF
OARO 11 Feb 2017
PPTX
6.1 Documentation.pptxxxxxxxxxxxxxxxxxxx
PPTX
GMP Training level next NS
PPTX
Documentation
PPTX
Manufacturing Documentation
PDF
Document Maintenance in Pharmaceutical Industry
PPTX
Common ways to avoid the most frequent GMP errors
PPTX
cGMP Guidelines According to Schedule M
PPTX
DOCUMENTATION PI.pptx
PDF
Drug Master Files (DMFs) - Understanding and Meeting Your Global Regulatory a...
PPTX
Pharmaceutical Good Manufacturing Practices
PPTX
Pharmaceutical Documentation
PDF
Optimize Your Process Validation Package
PPT
WHO- Self Inspection & Quality Audit_2012.ppt
PDF
Documentation in Pharmaceutical Industry
PPTX
WHO GMP Requirements
PPTX
Good manufacturing practices (schedule m)
The Emprove® Program: an introduction focussing on the Emprove® Suite and Emp...
Program - 5th Annual Biomanufacturing Summit 2013, San Diego
OARO 11 Feb 2017
6.1 Documentation.pptxxxxxxxxxxxxxxxxxxx
GMP Training level next NS
Documentation
Manufacturing Documentation
Document Maintenance in Pharmaceutical Industry
Common ways to avoid the most frequent GMP errors
cGMP Guidelines According to Schedule M
DOCUMENTATION PI.pptx
Drug Master Files (DMFs) - Understanding and Meeting Your Global Regulatory a...
Pharmaceutical Good Manufacturing Practices
Pharmaceutical Documentation
Optimize Your Process Validation Package
WHO- Self Inspection & Quality Audit_2012.ppt
Documentation in Pharmaceutical Industry
WHO GMP Requirements
Good manufacturing practices (schedule m)
Ad

More from Merck Life Sciences (20)

PDF
Launch of our new Titanium Dioxide Alternative
PDF
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
PDF
Use of Excipients in Downstream Processing to Improve Protein Purification
PDF
Exploring the protein stabilizing capability of surfactants against agitation...
PDF
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
PDF
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
PDF
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
PDF
The Future of Pharma- and Biopharmaceutical Audits
PDF
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
PDF
Identity testing by NGS as a means of risk mitigation for viral gene therapies
PDF
Latest advancements of melt based 3D printing technologies for oral drug deli...
PDF
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
PDF
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
PDF
Insights from a Global Collaboration Accelerating Vaccine Development with an...
PDF
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
PDF
Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...
PDF
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
PDF
The Developability Classification System (DCS): Enabling an Optimized Approac...
PDF
How to Accelerate and Enhance ADC Therapies
PDF
Regulatory Considerations for Excipients used in Lipid Nanoparticles
Launch of our new Titanium Dioxide Alternative
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
Use of Excipients in Downstream Processing to Improve Protein Purification
Exploring the protein stabilizing capability of surfactants against agitation...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Future of Pharma- and Biopharmaceutical Audits
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Identity testing by NGS as a means of risk mitigation for viral gene therapies
Latest advancements of melt based 3D printing technologies for oral drug deli...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Insights from a Global Collaboration Accelerating Vaccine Development with an...
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The Developability Classification System (DCS): Enabling an Optimized Approac...
How to Accelerate and Enhance ADC Therapies
Regulatory Considerations for Excipients used in Lipid Nanoparticles

Recently uploaded (20)

PPTX
different types of Gait in orthopaedic injuries
PPTX
community services team project 2(4).pptx
PDF
Priorities Critical Care Nursing 7th Edition by Urden Stacy Lough Test Bank.pdf
PPTX
Rheumatic heart diseases with Type 2 Diabetes Mellitus
PPTX
Galactosemia pathophysiology, clinical features, investigation and treatment ...
PDF
Selvita_Development-Strategy-2022-2025.pdf
PPTX
First aid in common emergency conditions.pptx
PPTX
General Pharmacology by Nandini Ratne, Nagpur College of Pharmacy, Hingna Roa...
PDF
A Brief Introduction About Malke Heiman
PPTX
Current Treatment Of Heart Failure By Dr Masood Ahmed
PDF
Dr. Jasvant Modi - Passionate About Philanthropy
PPTX
Nursing Care Aspects for High Risk newborn.pptx
PDF
Megan Miller Colona Illinois - Passionate About CrossFit
PPTX
Genaralised anxiety disorder presentation
PDF
Myers’ Psychology for AP, 1st Edition David G. Myers Test Bank.pdf
PPTX
Medical aspects of impairment including all the domains mentioned in ICF
PPTX
1. Drug Distribution System.pptt b pharmacy
PDF
DAY-6. Summer class. Ppt. Cultural Nursing
PPT
Adrenergic drugs (sympathomimetics ).ppt
PDF
Dr Masood Ahmed Expertise And Sucess Story
different types of Gait in orthopaedic injuries
community services team project 2(4).pptx
Priorities Critical Care Nursing 7th Edition by Urden Stacy Lough Test Bank.pdf
Rheumatic heart diseases with Type 2 Diabetes Mellitus
Galactosemia pathophysiology, clinical features, investigation and treatment ...
Selvita_Development-Strategy-2022-2025.pdf
First aid in common emergency conditions.pptx
General Pharmacology by Nandini Ratne, Nagpur College of Pharmacy, Hingna Roa...
A Brief Introduction About Malke Heiman
Current Treatment Of Heart Failure By Dr Masood Ahmed
Dr. Jasvant Modi - Passionate About Philanthropy
Nursing Care Aspects for High Risk newborn.pptx
Megan Miller Colona Illinois - Passionate About CrossFit
Genaralised anxiety disorder presentation
Myers’ Psychology for AP, 1st Edition David G. Myers Test Bank.pdf
Medical aspects of impairment including all the domains mentioned in ICF
1. Drug Distribution System.pptt b pharmacy
DAY-6. Summer class. Ppt. Cultural Nursing
Adrenergic drugs (sympathomimetics ).ppt
Dr Masood Ahmed Expertise And Sucess Story

The Emprove® Program: Introduction of New Portfolio Additions

  • 1. The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada. Emprove® Virtual User Group Meeting Torsten Schadendorf June 1st 2021
  • 2. The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
  • 3. Agenda 1 2 3 The Emprove® Program - an Overview Emprove® CCM Emprove® API Information Package 4 Technically Unavoidable Particle Profiles (TUPPs) - An Update
  • 4. The Emprove® Program – an Overview
  • 5. ... Convenient Access ... ... for a Broad Portfolio. ... to reliable information ... The Emprove® Program at a glance… Emprove® Virtual User Group Meeting | June 1st 2021 5
  • 6. Chemicals Expanding content PharmaGradeTM Integration in progress Filters & Single use Constant portfolio expansion, supporting launches Chromatography Launched Q2/2020 Cell Culture Media Launched Q4/2020 Emprove® Material Qualification Dossier Emprove® Quality Management Dossier Emprove® Operational Excellence Dossier Portfolio, Dossiers, Suite Emprove® Program Emprove® Suite Emprove® Virtual User Group Meeting | June 1st 2021 6
  • 7. POLL QUESTION 1 Title of Presentation | DD.MM.YYYY 7 Do the information in the Emprove® Dossiers and/or the Emprove® Suite help you to assess the risk associated with (please check all that apply)? o Raw Material Sourcing o Raw Material Qualification o Raw Material Performance o All of the Above
  • 9. Product Scope Emprove® CCM In scope  Chemically-defined media  Selected media for Gene Editing and Novel Modalities  Custom Media Product Family Cellvento® media (wave 1) EX-CELL® Advanced Media (wave 2) EX-CELL® Insect Media (wave 2) EX-CELL® Lenti Media (wave 2) Custom Media (wave 3) Emprove® Virtual User Group Meeting | June 1st 2021 9 Out of scope Standard / classical media (eg. DMEM, GMEM)
  • 10. Dossier Structure Emprove® CCM Emprove® Virtual User Group Meeting | June 1st 2021 10 Operational Excellence Dossier  Trace Element Information  Origin of Raw Materials  Analytical procedures Supports process optimization Material Qualification Dossier  General information  Specification  Manufacture  Address, Manufacturing Flowchart, ISO Cert, GMP Statement  Homogeneity Statement  Characterization Statements  TSE/BSE, Virus Safety, GMO, Components of Interest  Control of CCM  CoAs, Label, Batch Numbering  Container closure system  Stability Information to start a material qualification Quality Management Dossier  Supply Chain Information  Product Quality Self Assessment  Site Quality Self Assessment  Supplier Management  Stability data Answers questions during risk assessment
  • 11. Dossier Structure Emprove® CCM Emprove® Virtual User Group Meeting | June 1st 2021 11 Operational Excellence Dossier  Trace Element Information  Origin of Raw Materials  Analytical procedures Supports process optimization Material Qualification Dossier  General information  Specification  Manufacture  Address, Manufacturing Flowchart, ISO Cert, GMP Statement  Homogeneity Statement  Characterization Statements  TSE/BSE, Virus Safety, GMO, Components of Interest  Control of CCM  CoAs, Label, Batch Numbering  Container closure system  Stability Information to start a material qualification Quality Management Dossier  Supply Chain Information  Product Quality Self Assessment  Site Quality Self Assessment  Supplier Management  Stability data Answers questions during risk assessment
  • 12. Material Qualification Dossier Emprove® CCM Emprove® Virtual User Group Meeting | June 1st 2021 12  Specification  Originial Manufacturer  ISO 9001 Certificate
  • 13. Material Qualification Dossier Emprove® CCM Emprove® Virtual User Group Meeting | June 1st 2021 13  Specification  Originial Manufacturer  ISO 9001 Certificate  Manufacturing Process  Validation Report - Open Part  Packaging Material  CoA (examples)  Product label / batch numbering system (example)
  • 14. Material Qualification Dossier Emprove® CCM Emprove® Virtual User Group Meeting | June 1st 2021 14  Specification  Originial Manufacturer  ISO 9001 Certificate  Manufacturing Process  Validation Report - Open Part  Packaging Material  CoA (examples)  Product label / batch numbering system (example)  Certificates  TSE/BSE  Viral Safety  GMO  Homogeneity  Components of Interest
  • 15. Emprove® CCM Material Qualification Dossier Emprove® Virtual User Group Meeting | June 1st 2021 15
  • 16. Quality Management Emprove® CCM Emprove® Virtual User Group Meeting | June 1st 2021 16  IPEC-PQG GMP Guide applied to Cellvento® media platform with scope of Emprove® Program
  • 17. Dossier Structure Emprove® CCM Emprove® Virtual User Group Meeting | June 1st 2021 17 Operational Excellence Dossier  Trace Element Information  Origin of Raw Materials  Analytical procedures Supports process optimization Material Qualification Dossier  General information  Specification  Manufacture  Address, Manufacturing Flowchart, ISO Cert, GMP Statement  Homogeneity Statement  Characterization Statements  TSE/BSE, Virus Safety, GMO, Components of Interest  Control of CCM  CoAs, Label, Batch Numbering  Container closure system  Stability Information to start a material qualification Quality Management Dossier  Supply Chain Information  Product Quality Self Assessment  Site Quality Self Assessment  Supplier Management  Stability data Answers questions during risk assessment
  • 18. Quality Management Dossier Emprove® CCM Emprove® Virtual User Group Meeting | June 1st 2021 18
  • 19. Dossier Structure Emprove® CCM Emprove® Virtual User Group Meeting | June 1st 2021 19 Operational Excellence Dossier  Trace Element Information  Origin of Raw Materials  Analytical procedures Supports process optimization Material Qualification Dossier  General information  Specification  Manufacture  Address, Manufacturing Flowchart, ISO Cert, GMP Statement  Homogeneity Statement  Characterization Statements  TSE/BSE, Virus Safety, GMO, Components of Interest  Control of CCM  CoAs, Label, Batch Numbering  Container closure system  Stability Information to start a material qualification Quality Management Dossier  Supply Chain Information  Product Quality Self Assessment  Site Quality Self Assessment  Supplier Management  Stability data Answers questions during risk assessment
  • 20. Operational Excellence Dossier Emprove® CCM Emprove® Virtual User Group Meeting | June 1st 2021 20
  • 21. POLL QUESTION 2 Title of Presentation | DD.MM.YYYY 21 Please rank the following cell culture media information given in the Emprove® dossiers regarding the value for you (1 = highest value) o CCM stability data o Levels of trace elements o Origin of media components/ingredients Is ranking within poll questions possible? If not, please use this question: “Which of the following information shown before are of most value to you?”
  • 22. Emprove® CCM Dossier Availability (wave 1: Cellvento® media platform) Emprove® Virtual User Group Meeting | June 1st 2021 22 Article Code Product Emprove® Material Qualification Dossier Emprove® Quality Management Dossier Emprove® Operational Excellence Dossier 103840 Cellvento® 4CHO-X COMP Expansion √ √ √ 103796 Cellvento® 4Feed COMP New New New 103795 Cellvento® 4CHO New New New 101885 Cellvento® CHO-200 New New New 101883 Cellvento® Feed-200 New New New 102577 Cellvento® CHO-220 New New New 102578 Cellvento® Feed-220 New New New 102485 Cellvento® CHO-210 New New New 102488 Cellvento® Feed-210 New New New
  • 23. Versioning Emprove® CCM Emprove® Virtual User Group Meeting | June 1st 2021 23
  • 25. Emprove® Virtual User Group Meeting | June 1st 2021 25 Emprove® Essential  GMP (IPEC)  Moderate risk applications Emprove® Expert  GMP (IPEC)  Higher risk applications Emprove® API  GMP (ICH Q7) Chemicals Categories Emprove® Evolve  Non-GMP, manufactured utilizing GMP concepts and elements  Evolving regulatory needs Emprove® Program for Chemicals
  • 26. Content Emprove® API Information Package Emprove® Virtual User Group Meeting | June 1st 2021 26  General Information  Manufacture  Manufacturer  Certificate of GMP Compliance  Description of Manufacturing Process  Specification  Other relevant product certificates  Product Quality Self Assessment  Packaging Information  Stability Summary and Conclusion Purpose: Supporting material qualification, not for registration purposes
  • 27. Certificate of GMP Compliance (latest version available on EudraGMDP webpage*) Emprove® API Information Package Emprove® Virtual User Group Meeting | June 1st 2021 27 * http://eudragmdp.ema.europa.eu/inspections/gmpc/searchGMPCompliance.do;jsessionid=FdxKinNcvHto_mTjMJAtz3O1xm1iK0yrk07LmD-rcl4bCSJrozh6!814916889
  • 28. Other relevant product certificates Package Emprove® API Information Package Emprove® Virtual User Group Meeting | June 1st 2021 28  TSE/BSE  Allergen  Mycotoxin/Aflatoxin  GMO  Nitrosamine  Melamine  Kosher  Halal
  • 29. Stability Summary and Conclusion Emprove® API Information Package Emprove® Virtual User Group Meeting | June 1st 2021 29
  • 30. POLL QUESTION 3 Title of Presentation | DD.MM.YYYY 30 Do you use APIs only for the intended use as API or (potentially) also in other / adjacent applications (e.g. as excipients in critical formulations)? o Only as API o APIs and further/other applications
  • 31. Versioning Emprove® API Information Package Emprove® Virtual User Group Meeting | June 1st 2021 31
  • 32. Article Product Name Dossier Availability 108432 Urea cryst. EMPROVE® API Ph Eur, BP, USP √ 100164 Boric acid cryst., EMPROVE® API Ph Eur, BP, NF √ 105040 Potassium iodide EMPROVE® API Ph Eur, BP, JP, USP √ 109828 di-Potassium hydrogen phosphate anhydrous, low in sodium EMPROVE® API Ph Eur, BP, USP √ 106235 Sodium acetate trihydrate EMPROVE® API Ph Eur, BP, JP, USP, FCC, E262 New 106666 tri-Sodium citrate dihydrate low in endotoxins, EMPROVE® API Ph Eur, BP, JP, USP New 102465 Calcium chloride dihydrate EMPROVE® API Ph Eur, BP, JP, USP New 102367 Magnesium chloride hexahydrate cryst. EMPROVE® API Ph Eur, BP, JPC, USP New 500111 Cocarboxylase tetrahydrate EMPROVE® API HY2 / 2021 500112 Cocarboxylase chloride thiamine diphosphoric acid ester chloride EMPROVE® API HY2 / 2021 500667 Thiamine phosphoric acid ester chloride dihydrate EMPROVE® API HY2 / 2021 106441 Sodium fluoride EMPROVE® API Ph Eur, BP, USP HY2 / 2021 106444 Sodium chloride EMPROVE® API Ph Eur, BP, JP, USP HY2 / 2021 108815 Zinc chloride EMPROVE® API Ph Eur, BP, USP HY2 / 2021 106143 Meglumine low in endotoxins EMPROVE® API Ph Eur, ChP, JP, USP HY2 / 2021 128204 Sodium acetate trihydrate EMPROVE® API Ph Eur, BP, JP, USP, FCC, E262 HY2 / 2021 Expected Availability Emprove® API Information Packages 32 Emprove® Virtual User Group Meeting | June 1st 2021
  • 34. Detailed information for each type of TUP From Reactive to Proactive Emprove® Virtual User Group Meeting | June 1st 2021 34  Intention, quality policy towards foreign particles  Flow chart of manufacturing process (reference to MQD)  TUP information  Particle picture  Identity and composition  Mass balance  Root cause  Assessment of additional microbial and BSE risks
  • 35. Detailed information for each type of TUP Picture and Identity 35 Emprove® Virtual User Group Meeting | June 1st 2021
  • 36. Detailed information for each type of TUP Picture and Identity Emprove® Virtual User Group Meeting | June 1st 2021 36
  • 37. Availability Technically Unavoidable Particle Profile (TUPP) Emprove® Virtual User Group Meeting | June 1st 2021 37 Article Product 100419 Parteck® M 200 (Mannitol) EMPROVE® ESSENTIAL Ph Eur,BP,JP,USP,E 421 100494 Parteck® M 100 (Mannitol) EMPROVE® ESSENTIAL Ph Eur,BP,JP,USP,E 421 100892 Sucrose low in endotoxins suitable for use as excipient EMPROVE® exp Ph Eur,BP,JP,NF 107653 Sucrose EMPROVE® ESSENTIAL Ph Eur,BP,JP,NF 101816 Ammonium sulfate EMPROVE® EXPERT ACS,NF 112120 Calcium carbonate precipitated (<= 0.0001% Al) EMPROVE® ESSENTIAL Ph Eur,BP,USP,JP,FCC,E 170 102064 Calcium carbonate precipitated (<= 0.002% Fe) EMPROVE® ESSENTIAL Ph Eur,BP,USP,JP,FCC 106400 Sodium chloride EMPROVE® ESSENTIAL Ph Eur,BP,USP 116224 Sodium chloride low in endotoxins suitable for use as excipient EMPROVE® exp Ph Eur,BP,JP,USP 137017 Sodium chloride EMPROVE® EXPERT Ph Eur,BP,ChP,JP,USP 106482 Sodium hydroxide pellets EMPROVE® ESSENTIAL Ph Eur,BP,FCC,JP,NF,E 524 137020 Sodium hydroxide pellets suitable for the biopharmaceutical production EMPROVE® bio Ph Eur,BP,JP,NF 108346 D(+)-Glucose monohydrate EMPROVE® EXPERT Ph Eur,BP,USP 141350 Polyvinyl alcohol 4-88 EMPROVE® ESSENTIAL Ph Eur,USP,JPE 141351 Polyvinyl alcohol 8-88 EMPROVE® ESSENTIAL Ph Eur,USP,JPE 141352 Polyvinyl alcohol 26-88 EMPROVE® ESSENTIAL Ph Eur,USP,JPE 141353 Polyvinyl alcohol 40-88 EMPROVE® ESSENTIAL Ph Eur,ChP,USP,JPE 141354 Polyvinyl alcohol 5-88 EMPROVE® ESSENTIAL Ph Eur,USP,JPE 141355 Polyvinyl alcohol 18-88 EMPROVE® ESSENTIAL Ph Eur,ChP,USP,JPE 103583 Parteck® SI 150 (Sorbitol) EMPROVE® ESSENTIAL Ph Eur,BP,JP,NF,JSFA,E 420 115079 Parteck® SI 200 (Sorbitol) EMPROVE® ESSENTIAL Ph Eur,BP,JP,NF,E 420 112635 Parteck® Delta M (Mannitol) EMPROVE® ESSENTIAL Ph Eur,BP,USP,JP,E 421 100493 Parteck® M 300 (Mannitol) EMPROVE® ESSENTIAL Ph Eur,BP,JP,USP,E 421 137112 Poloxamer 188 EMPROVE® EXPERT
  • 38. New Technically Unavoidable Particle Profiles (TUPPs) Emprove® Virtual User Group Meeting | June 1st 2021 38 Article Product TUPP part of Emprove® OED 105911 Maltose monohydrate EMPROVE® ESSENTIAL Mar 2021 104871 Potassium dihydrogen phosphate cryst., EMPROVE® ESSENTIAL Ph Eur,BP,JPC,NF,E 340 May 2021 137039 Potassium dihydrogen phosphate cryst. EMPROVE® EXPERT Ph Eur,BP,JPC,NF May 2021 105101 di-Potassium hydrogen phosphate anhydrous, EMPROVE® ESSENTIAL Ph Eur,BP,E 340 May 2021 137010 di-Potassium hydrogen phosphate anhydrous EMPROVE® EXPERT Ph Eur,BP,USP May 2021 106349 Sodium dihydrogen phosphate monohydrate EMPROVE® ESSENTIAL BP,USP May 2021 137093 Sodium dihydrogen phosphate monohydrate EMPROVE® EXPERT BP,USP May 2021 106574 di-Sodium hydrogen phosphate heptahydrate EMPROVE® ESSENTIAL DAC,USP May 2021 137092 di-Sodium hydrogen phosphate heptahydrate EMPROVE® EXPERT DAC,USP May 2021 106398 Sodium carbonate anhydrous EMPROVE® ESSENTIAL Ph Eur,BP,JP,NF June / July 137012 Sodium acetate trihydrate EMPROVE® EXPERT Ph Eur,BP,JP,USP June / July 105032 Potassium hydroxide pellets EMPROVE® ESSENTIAL Ph Eur,BP,JP,NF,FCC,E 525 TUPP to be created
  • 39. Emprove® Suite Notification System Last but not least Receive a monthly digest of the updates that were made in the previous month to:  Emprove® Operational Excellence Dossiers  Emprove® Quality Management Dossiers 1 Click on “Be notified of changes to subscription documents” 2 Submit your name and confirm the notification 3
  • 40. The vibrant M, SAFC, Millipore, Cellvento, and Emprove are trademarks of Merck KGaA, Darmstadt, Germany or its affiliates. All other trademarks are the property of their respective owners. Detailed information on trademarks is available via publicly accessible resources. © 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.